Swiss National Bank Has $86.29 Million Holdings in Humana Inc. (NYSE:HUM)

Swiss National Bank cut its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 4.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 340,100 shares of the insurance provider's stock after selling 17,500 shares during the quarter. Swiss National Bank owned approximately 0.28% of Humana worth $86,287,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ashton Thomas Securities LLC acquired a new position in Humana in the third quarter valued at about $31,000. FPC Investment Advisory Inc. acquired a new position in shares of Humana in the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new stake in Humana during the 4th quarter worth approximately $30,000. OFI Invest Asset Management acquired a new stake in Humana during the 4th quarter valued at $33,000. Finally, Atwood & Palmer Inc. raised its position in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 60 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Trading Down 1.0 %

Shares of NYSE HUM traded down $2.77 during midday trading on Wednesday, reaching $267.01. 1,508,462 shares of the stock were exchanged, compared to its average volume of 1,714,292. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a market capitalization of $32.23 billion, a price-to-earnings ratio of 26.84, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business has a 50-day simple moving average of $271.45 and a two-hundred day simple moving average of $278.29.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is currently 35.58%.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research reports. StockNews.com lowered Humana from a "buy" rating to a "hold" rating in a research note on Tuesday. Truist Financial boosted their target price on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Barclays boosted their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 13th. Finally, Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $285.68.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.37% of the company's stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.